Lumanity Acquires Clarion Healthcare from Svoboda Capital Partners
November 8, 2022
Lumanity, a portfolio company of Arsenal Capital Partners, has acquired Boston-based life sciences consultancy Clarion Healthcare from Svoboda Capital Partners. The undisclosed transaction expands Lumanity’s U.S. commercialization and product lifecycle consulting capabilities and creates greater global scale for life sciences strategy services.
- Buyers
- Lumanity, Arsenal Capital Partners
- Targets
- Clarion Healthcare
- Sellers
- Svoboda Capital Partners
- Platforms
- Lumanity
- Industry
- Healthcare Services
- Location
- Massachusetts, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Lumanity Acquires Innovative Edge
March 30, 2022
Healthcare Services
Lumanity, a portfolio company backed by Arsenal Capital Partners, has acquired Innovative Edge (IE), a UK-based provider of pharmaceutical product launch and commercialization services. The add-on strengthens Lumanity's end-to-end commercialization and launch capabilities by integrating IE's Launch EcoSystem and Ignite collaborative launch platform into Lumanity's existing life‑sciences services.
-
Lumanity Acquires Endpoint Outcomes
June 14, 2022
Healthcare Services
Lumanity has acquired Endpoint Outcomes, a specialist in patient-centered clinical outcomes assessments, to strengthen and broaden its health economics and outcomes research (HEOR) capabilities. The acquisition integrates Endpoint's COA expertise with Lumanity's existing HEOR, medical, commercial, and regulatory capabilities to create a comprehensive global HEOR service offering.
-
Bridges Consumer Healthcare Acquires Clarion Brands from Swander Pace Capital
January 21, 2021
Consumer Products
Bridges Consumer Healthcare LLC, a Charlesbank Capital Partners-backed platform, has acquired Clarion Brands, LLC from Swander Pace Capital. The transaction adds Clarion's portfolio of niche OTC and dietary supplement brands — including Florajen, Lipo-Flavonoid and Certain Dri — to Bridges' ThermaCare platform to drive scale, marketing and distribution expansion.
-
Navitus Health Solutions Acquires EpiphanyRx; Lumicera Purchases Quality Drug Clinical Care
July 19, 2021
Healthcare Services
Navitus Health Solutions has acquired EpiphanyRx to broaden its PBM capabilities and mid-market employer reach. Its specialty pharmacy arm, Lumicera Health Services, also acquired Quality Drug Clinical Care in Irvine, California to expand Lumicera's specialty pharmacy footprint and HIV clinical services in the western United States.
-
Health Catalyst Acquires Lumeon Limited
August 8, 2024
Healthcare Services
Health Catalyst, Inc. (Nasdaq: HCAT) has completed its acquisition of Lumeon Limited, a digital health company that provides care orchestration software used by provider organizations in the U.S. and United Kingdom. The deal combines Lumeon's Care Orchestration platform with Health Catalyst's analytics and AI capabilities to expand clinical automation, improve care coordination, and support international growth, particularly in the U.K.
-
Lucid Group Acquires HealthCare21
September 12, 2019
Healthcare Services
Lucid Group, backed by private equity partner LDC, has acquired HealthCare21, a 23-year-old healthcare communications consultancy. The add-on expands Lucid's scientific, editorial and digital capabilities and increases its footprint in the North West of the United Kingdom while supporting broader international reach.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.